• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·2158.HK
Share

Yidu Tech Inc. Stocks

HK$ 5.35Last Updated 16.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 695.98M

HK$ 5.35
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overpriced on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 2158.HK is 9.47 and suggests 84.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.07.2026 13:00

"Weeks, not months": The IEA warned of the threat of a global crisis over the Strait of Hormuz

16.07.2026 11:30

Strive has been paying dividends every day for a month now. What risks does the company face?

16.07.2026 10:45

Samsung and SK Hynix shares plummeted ahead of TSMC's earnings report. The market is waiting for signals regarding AI

16.07.2026 10:30

Morning Roundup: New Strikes on Iran, Anthropic Heads Toward an IPO, and a Sell-Off in Asia

16.07.2026 09:30

"Market Leaders Face a Test of Resilience": Goldman Explains How to Protect Your Portfolio

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026